Virus protease
From Proteopedia
(Difference between revisions)
| Line 26: | Line 26: | ||
*[[SARS Coronavirus Main Proteinase]]<br /> | *[[SARS Coronavirus Main Proteinase]]<br /> | ||
*[[SARS-CoV-2 Coronavirus Main Protease]]<br /> | *[[SARS-CoV-2 Coronavirus Main Protease]]<br /> | ||
| + | *[[Taylor SARS-CoV2 Protease]]<br /> | ||
== 3D Structures of Virus protease == | == 3D Structures of Virus protease == | ||
[[Virus protease 3D structures]] | [[Virus protease 3D structures]] | ||
Current revision
| |||||||||||
References
- ↑ Wanga QM, Chen SH. Human rhinovirus 3C protease as a potential target for the development of antiviral agents. Curr Protein Pept Sci. 2007 Feb;8(1):19-27. PMID:17305557
- ↑ Matthews DA, Dragovich PS, Webber SE, Fuhrman SA, Patick AK, Zalman LS, Hendrickson TF, Love RA, Prins TJ, Marakovits JT, Zhou R, Tikhe J, Ford CE, Meador JW, Ferre RA, Brown EL, Binford SL, Brothers MA, DeLisle DM, Worland ST. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11000-7. PMID:10500114
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky
